What Directive 2011/62/EU of the European Parliament and of the Council of 8 June 2011 on the prevention of the entry into the legal supply chain of falsified medicinal products for human use, amending Directive 2001/83/EC and Regulation (EC) No 726/2004 of the European Parliament and of the Council and repealing Directive 2004/27/EC requires
This directive mandates that all prescription medicines placed on the EU market must bear a unique identifier (UI) and tamper-evident feature (TEF), with verification at the point of dispensing…
This is a preview. The full record adds the complete summary, 8 workflow steps, 10 schema fields and 5 primary citations. Start a free trial or see pricing.
Pillar: Pharmaceuticals & Life Sciences · Authority: European Commission · Version: 1.0.0 · Last updated:
Primary source: https://eur-lex.europa.eu/legal-content/EN/TXT/?uri=CELEX%3A32011L0062
SHA-256 integrity: 1f812843bdb6e02bee2f64bb8c943f394c6e5066c9c26573cea7fefed21ed414
Primary Citations — 5 traced to source
- Directive 2011/62/EU, Article 1 - Amendments to Directive 2001/83/EC concerning prevention of falsified medicinal products
- Directive 2001/83/EC, Article 54a - Safety features for medicinal products for human use
+ 3 more citations (full bibliography, deterministic workflow, actionable schema and crosswalks) included in the vault unlock — $0.01 via Skyfire / L402 / Direct Base USDC.
Access
- Discovery (free): /api/v1/nodes/eu-falsified-medicines-directive-2011-62-ec.json — 6-field metadata
- Vault (full node): /api/v1/vault/nodes/eu-falsified-medicines-directive-2011-62-ec.json — full 13-key payload, $0.01 USDC (L402/Skyfire/Direct Base)
- Canonical URL: https://bidda.com/intelligence/eu-falsified-medicines-directive-2011-62-ec
- Back to registry: Browse all 10,102 compliance nodes